Matches in Wikidata for { <http://www.wikidata.org/entity/Q64352141> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q64352141 description "clinical trial" @default.
- Q64352141 description "ensayu clínicu" @default.
- Q64352141 description "klinisch onderzoek" @default.
- Q64352141 description "клінічне випробування" @default.
- Q64352141 description "կլինիկական փորձարկում" @default.
- Q64352141 name "An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IM" @default.
- Q64352141 type Item @default.
- Q64352141 label "An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IM" @default.
- Q64352141 prefLabel "An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IM" @default.
- Q64352141 P1050 Q64352141-E5126D47-F03C-407D-B704-9612D5FF754D @default.
- Q64352141 P1132 Q64352141-C60C9DD0-EF8A-4606-B3F6-BEE64ABA76C6 @default.
- Q64352141 P1476 Q64352141-78999E1A-8EB3-4154-8623-68350BF54C23 @default.
- Q64352141 P17 Q64352141-2C150728-71C9-4B78-9012-6717BCC53D87 @default.
- Q64352141 P17 Q64352141-749CB198-7207-4FBE-842A-031040B5C37A @default.
- Q64352141 P17 Q64352141-75A157F1-1B30-40B6-A711-E095BC9172C0 @default.
- Q64352141 P2899 Q64352141-D40F153B-86E7-4948-A88D-57FACEBBB44E @default.
- Q64352141 P3098 Q64352141-C7D1411F-DE00-4251-8CCE-3E40EEFA0D4B @default.
- Q64352141 P31 Q64352141-2BB6D433-B574-4C26-8A29-66AB6228F7B8 @default.
- Q64352141 P4844 Q64352141-2E1EB9C4-48F2-4E1F-8D21-A0064C347666 @default.
- Q64352141 P4844 Q64352141-4A8808DC-D93B-4867-BDB5-3C9D59F5A4BB @default.
- Q64352141 P4844 Q64352141-66B08134-AB3A-433F-BF90-74CD72D90D87 @default.
- Q64352141 P4844 Q64352141-72C71DC1-C9B4-4A0A-9411-D59336FB3673 @default.
- Q64352141 P4844 Q64352141-7FB8AF10-20FF-493B-9041-0A499B9F7AAA @default.
- Q64352141 P4844 Q64352141-9876855F-9526-41B7-9220-BDB3E10D8CD2 @default.
- Q64352141 P4844 Q64352141-BBE1F096-6F2A-4917-86B5-AD087FE73396 @default.
- Q64352141 P4844 Q64352141-E9B797F8-67DB-4F51-9840-82BD89946FE6 @default.
- Q64352141 P4844 Q64352141-F2FEFD26-BC9E-4528-98FB-B40C828790BF @default.
- Q64352141 P580 Q64352141-C80F3763-6AE0-4F26-8618-90EAAFCDD301 @default.
- Q64352141 P582 Q64352141-783A89CC-3BFB-43EF-9E39-03CE7DBBC957 @default.
- Q64352141 P6099 Q64352141-BA452A1F-1022-48AE-A8C1-0DEC98F2BCE5 @default.
- Q64352141 P8363 Q64352141-0FE587A7-C9F5-42C9-A83A-4E4217634609 @default.
- Q64352141 P921 Q64352141-C5E53AB4-2D31-4A9B-9F0F-B2AC6B71A7BC @default.
- Q64352141 P1050 Q467635 @default.
- Q64352141 P1132 "+124" @default.
- Q64352141 P1476 "An Open-label, Multicenter, Phase 2 Trial Investigating the Efficacy and Safety of Daratumumab in Subjects With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor and IMiD) or Are Double Refractory to a Proteasome Inhibitor and an IMiD" @default.
- Q64352141 P17 Q16 @default.
- Q64352141 P17 Q29 @default.
- Q64352141 P17 Q30 @default.
- Q64352141 P2899 "+18" @default.
- Q64352141 P3098 "NCT01985126" @default.
- Q64352141 P31 Q30612 @default.
- Q64352141 P4844 Q11426176 @default.
- Q64352141 P4844 Q27108063 @default.
- Q64352141 P4844 Q27262132 @default.
- Q64352141 P4844 Q27266327 @default.
- Q64352141 P4844 Q413486 @default.
- Q64352141 P4844 Q417222 @default.
- Q64352141 P4844 Q422970 @default.
- Q64352141 P4844 Q5222113 @default.
- Q64352141 P4844 Q57055 @default.
- Q64352141 P580 "2013-09-27T00:00:00Z" @default.
- Q64352141 P582 "2015-01-09T00:00:00Z" @default.
- Q64352141 P6099 Q42824440 @default.
- Q64352141 P8363 Q78089383 @default.
- Q64352141 P921 Q17145978 @default.